Original text
Rate this translation
Your feedback will be used to help improve Google Translate

F-Listed

2383 companies·Curated

Top companies trading on F, ranked by market cap.

Germany2383
F2383
Yesterday
Scibase AbBusiness
SciBase publishes the Annual report for 2025
a day ago
Caretrust Reit Dl-01Business
CareTrust REIT Announces Approximately $628 Million of Investments
a day ago
Caretrust Reit Dl-01Business
CareTrust REIT Receives Investment Grade Rating Upgrade from Moody’s
a day ago
Aspo OyjBusiness
Aspo Plc’s Interim Report, January 1 – March 31, 2026: Stable performance in a challenging operating environment
a day ago
Nb Private Equity Part.aBusiness
NBPE Announces Audited Annual Financial Report and 31 March 2026 monthly NAV
a day ago
Ctp N.v.Business
CTP secures long-term 46,000 sqm lease extension with mail order company Walz in Bad Waldsee, Germany
2 days ago
Biotalys NvBusiness
Biotalys Achieves First U.S. State Registration for EVOCA in Florida
2 days ago
Apr 24 2026
Orca Energy Group BBusiness
Orca Announces 2026 Annual General and Special Meeting
4 days ago
Four Corners Property Tr.Business
FCPT Announces Acquisition of a Fogo de Chão Property for $5.7 Million
4 days ago
Dri Healthcare Trust UtBusiness
DRI Healthcare to Host First Quarter 2026 Earnings Call and Webcast on May 15, 2026
4 days ago
Bioretec OyBusiness
Final results of Bioretec Ltd's rights issue
4 days ago
Aelis Farma SaBusiness
Aelis Farma: Availability of the 2025 Universal Registration Document
4 days ago
AdvicenneBusiness
Advicenne 2025 Universal Registration Document Made Available
4 days ago
Sivers Ima Holding AbBusiness
Sivers Semiconductors AB Postpones Publication of Annual Report 2025 Amid Dual Listing Evaluation
4 days ago
Apollo Commercial Real Estate Finance IncBusiness
Apollo Commercial Real Estate Finance, Inc. Completes Sale of Commercial Real Estate Loan Portfolio
4 days ago
Nnit AsBusiness
NNIT A/S: NNIT updates its financial disclosure
4 days ago
Aspo OyjBusiness
Aspo to publish Interim Report for January-March 2026 on Monday, April 27, 2026
4 days ago
Munters Group AbBusiness
Munters wins order of BSEK 2.0 for a modular AI cooling solution
4 days ago
Vistin Pharma AsaBusiness
Vistin Pharma ASA: First quarter 2026 financial results
4 days ago
Apr 23 2026
Gruvaktiebolaget ViscariaBusiness
Elemental Royalty Provides Portfolio Update
5 days ago
Business
Yesterday
Less than 1 min read

SciBase publishes the Annual report for 2025

STOCKHOLM, April 27, 2026 /PRNewswire/ -- SciBase hereby announces that the Annual report for 2025 is available at the Company's website www.scibase.com.

A pdf-version of the annual report is enclosed to this press-release.

A printed version of the Annual report will only be distributed to shareholders who actively request a printed copy.

For more information, please contact:

Michael Colérus, CFO
Tel: +46 70 341 34 72

E-mail: [email protected]

Certified Advisor:

DNB Carnegie Investment Bank AB (publ)
Tel: +46 8 588 68 570
Email: [email protected]

The information was submitted for publication, through the agency of the contact person set out above, at 16.00 CET on April 27, 2026.

About SciBase and Nevisense
SciBase is a global medical technology company, specializing in early detection and prevention in dermatology. SciBase develops and commercializes Nevisense, a unique point-of-care platform that combines AI (artificial intelligence) and advanced EIS technology to enhance diagnostic accuracy, ensuring proactive skin health management.

Our commitment is to minimize patient suffering, allowing clinicians to improve and save lives through timely detection and intervention and reduce healthcare costs.

Built on more than 20 years of research at Karolinska Institute in Stockholm, Sweden, SciBase is a leader in dermatological advancements.

The company has been on the Nasdaq First North Growth Market exchange since June 2, 2015 and the company's Certified Adviser is Carnegie Investment Bank AB (publ). Learn more at www.scibase.com. For press releases and financial reports visit: http://investors.scibase.se/en/pressreleases

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/scibase/r/scibase-publishes-the-annual-report-for-2025,c4340753

The following files are available for download:

https://mb.cision.com/Main/12371/4340753/4060452.pdf

Annual-Report-2025-final

https://mb.cision.com/Public/12371/4340753/bb460f6f2a256f41.pdf

PR Annual Report 2025

Cision

View original content:https://www.prnewswire.co.uk/news-releases/scibase-publishes-the-annual-report-for-2025-302754344.html

DISCLAIMER OF LIABILITY

6ix Inc. ("6ix") licenses software to publicly traded issuers of securities ("Issuers" and each an "Issuer") which can be used by Issuers to communicate with current and prospective investors ("Investors" and each an "Investor") on the online platform maintained by 6ix Inc. at www.6ix.com (the "Platform"). Each Issuer is solely responsible for all content relating to the Issuer on the 6ix Platform, including without limitation all investor summits presented by the Issuer and all summary information about the Issuer on the 6ix Platform.

All content provided on the 6ix Platform is for informational and educational purposes only and should not be construed as investment advice or an offer or solicitation in respect to any products or services. The content presented on the 6ix Platform should not be used as the basis for any investment decision, and does not purport to provide any legal, tax or accounting advice. There are inherent risks involved with investing in Issuers, as set out in the public disclosure record of each Issuer. Issuers are not responsible for revising or updating any information that they present on the 6ix Platform.

Investors should refer to the continuous disclosure documents filed by each Issuer under applicable securities laws, including risk factors and warnings regarding "forward looking information". Issuers are solely responsible for compliance with applicable securities laws, and 6ix makes no representations and provides no assurances to Investors regarding the accuracy or truthfulness of information presented by Issuers on the 6ix Platform or in their public disclosure records.

6ix is not licensed to trade, deal or advise in securities in any jurisdiction. 6ix does not recommend or endorse any Issuer on the 6ix Platform, nor does 6ix verify the accuracy of any information presented by Issuers to Investors on the 6ix Platform or in their public disclosure records. 6ix's sole responsibility as the operator of the 6ix Platform is to provide software to Issuers and Investors through which Issuers and Investors communicate directly with each other without any intermediation or intervention by 6ix other than in respect of technical, logistical or advertising and marketing support. Issuers pay 6ix a licensing fee for use of the 6ix Platform, and 6ix may also receive payment from Issuers to pay for advertising on third-party websites. 6ix and its principals may make and hold investments in securities of Issuers on the 6ix Platform and 6ix may offer reduced rates for its software services to Issuers in which 6ix and/or its principals are invested.

ALL CONTENT ON THE PLATFORM IS PROVIDED BY THE ISSUERS "AS IS" AND "AS AVAILABLE". 6IX DOES NOT GUARANTEE THE ACCURACY OF ITS CONTENT. BY USING THE PLATFORM, EACH INVESTOR AGREES TO ACCEPT ANY RISKS ASSOCIATED WITH THE USE OF THE PLATFORM AND ACKNOWLEDGES THAT 6IX IS NOT RESPONSIBLE FOR ANY CONTENT PRESENTED BY OR RELATING TO ISSUERS ON THE PLATFORM.

6IX DOES NOT WARRANT THAT THE PROVISION OF INFORMATION BY ISSUERS ON THE PLATFORM WILL BE ERROR-FREE, TIMELY, COMPLETE OR ACCURATE. USE OF THE PLATFORM AND RELIANCE THEREON IS AT INVESTOR'S SOLE RISK. 6IX WILL NOT BE IN ANY WAY BE LIABLE TO ANY INVESTOR OR ISSUER OR ANY OTHER ENTITY OR PERSON FOR ANY INACCURACIES, ERRORS, OMISSIONS, DELAYS, DAMAGES, CLAIMS, LIABILITIES OR LOSSES, REGARDLESS OF CAUSE, IN OR ARISING FROM THE USE OF THE PLATFORM.

IN NO EVENT WILL 6IX BE LIABLE FOR ANY DAMAGES, INCLUDING WITHOUT LIMITATION DIRECT OR INDIRECT, SPECIAL, INCIDENTAL, OR CONSEQUENTIAL DAMAGES, LOSSES OR EXPENSES ARISING IN CONNECTION WITH THE USE OF THE PLATFORM BY INVESTORS AND/OR ISSUERS EVEN IF 6IX IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES, LOSSES OR EXPENSES. FURTHER, 6IX SHALL NOT BE LIABLE IN ANY MANNER FOR THE PRODUCT OR SERVICES OF ANYONE WHO REDISTRIBUTES THE INFORMATION PROVIDED ON THE PLATFORM, AND SUCH REDISTRIBUTION IS EXPRESSLY PROHIBITED.